These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10917789)

  • 21. Salvage therapy for patients failing their current antiretroviral regimen.
    Albrecht MA
    AIDS Clin Rev; 2000-2001; ():139-91. PubMed ID: 10999220
    [No Abstract]   [Full Text] [Related]  

  • 22. HIV resistance testing benefit is shown.
    AIDS Alert; 2001 Oct; 16(10):136. PubMed ID: 11590937
    [No Abstract]   [Full Text] [Related]  

  • 23. HIV resistance testing proves its value.
    Proj Inf Perspect; 1999 Sep; (28):14. PubMed ID: 11367356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A combinatorial ledge: reverse transcriptase fidelity, total body viral burden, and the implications of multiple-drug HIV therapy for the evolution of antiviral resistance.
    Colgrove R; Japour A
    Antiviral Res; 1999 Feb; 41(1):45-56. PubMed ID: 10321578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antiretroviral drug resistance].
    Menéndez MA; Pérez de Oteyza C
    Enferm Infecc Microbiol Clin; 2001; 19(6):287-90. PubMed ID: 11440677
    [No Abstract]   [Full Text] [Related]  

  • 26. Report from the 4th International Workshop on HIV Drug Resistance and Treatment Strategies.
    O'Brien W
    Res Initiat Treat Action; 2000 Sep; 6(3):26-9. PubMed ID: 11708164
    [No Abstract]   [Full Text] [Related]  

  • 27. How testing for HIV resistance influences therapeutic decision making. Analysis of a sample of 600 clinicians.
    Mascolini M; Wensing AM; Boucher CA
    IAPAC Mon; 2001 Mar; 7(3):85-90. PubMed ID: 11697306
    [No Abstract]   [Full Text] [Related]  

  • 28. The benefits of HIV resistance testing in optimizing drug discovery.
    Heilek-Snyder G; Bean P
    Am Clin Lab; 2002 Oct; 21(8):13-4. PubMed ID: 12440169
    [No Abstract]   [Full Text] [Related]  

  • 29. [Comparative analysis of methods for detecting resistance].
    Erice A; Pérez JL; Pumarola T
    Enferm Infecc Microbiol Clin; 2001 Feb; 19(Monografico):14-21. PubMed ID: 11428053
    [No Abstract]   [Full Text] [Related]  

  • 30. [Light and shade on the treatment of HIV infection].
    Takata N
    Rinsho Ketsueki; 2001 Jun; 42(6):476-80. PubMed ID: 11505526
    [No Abstract]   [Full Text] [Related]  

  • 31. The role of viral dynamics in the pathogenesis of HIV disease and implications for antiviral therapy.
    Havlir DV; Richman DD
    Springer Semin Immunopathol; 1997; 18(3):267-83. PubMed ID: 9089949
    [No Abstract]   [Full Text] [Related]  

  • 32. [Some aspects of the pathogenesis of HIV infection].
    Eremin VF; Votiakov VI; Titov LP
    Mol Biol (Mosk); 1998; 32(6):933-9. PubMed ID: 9929867
    [No Abstract]   [Full Text] [Related]  

  • 33. Baseline antiretroviral resistance and clinical outcomes in an urban HIV clinic.
    Klibanov OM; Dolder CR; Assefa F; Ekwonu TJ
    AIDS Patient Care STDS; 2013 Apr; 27(4):205-7. PubMed ID: 23514132
    [No Abstract]   [Full Text] [Related]  

  • 34. Highlights of the Fourth International Workshop on HIV Drug Resistance.
    Lange JM; deJong MD
    J Int Assoc Physicians AIDS Care; 1995 Aug; 1(7):25-7. PubMed ID: 11362748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. International perspectives on antiretroviral resistance. Introduction.
    Volberding P; Lange J
    J Acquir Immune Defic Syndr; 2001 Mar; 26 Suppl 1():S1-2. PubMed ID: 11265002
    [No Abstract]   [Full Text] [Related]  

  • 36. Putting resistance to the test.
    Daar ES
    Posit Living; 2001 Apr; 10(3):15-6, 43-6. PubMed ID: 11548369
    [No Abstract]   [Full Text] [Related]  

  • 37. Rapid assay for HIV drug resistance.
    Am Fam Physician; 1997 Oct; 56(6):1676-7. PubMed ID: 9351434
    [No Abstract]   [Full Text] [Related]  

  • 38. [Determining resistance in HIV therapy. Careful interpretation only].
    MMW Fortschr Med; 2001 Apr; 143 Suppl 1():54-5. PubMed ID: 11373784
    [No Abstract]   [Full Text] [Related]  

  • 39. Revisiting resistance (this isn't getting any easier).
    Mascolini M
    IAPAC Mon; 2000 Aug; 6(8):221-38. PubMed ID: 11299604
    [No Abstract]   [Full Text] [Related]  

  • 40. Prevalence of drug resistance-related mutations among HIV-1s in Japan.
    Sugiura W; Matsuda M; Abumi H; Yamada K; Taki M; Ishikawa M; Miura T; Fukutake K; Gouchi K; Ajisawa A; Iwamoto A; Hanabusa H; Mimaya J; Takamatsu J; Takada N; Kakishita E; Yoshioka A; Kashiwagi S; Shirahata A; Nagai Y
    Jpn J Infect Dis; 1999 Feb; 52(1):21-2. PubMed ID: 10808258
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.